BF
Insider buying
Bart Filius bought $231K of PRQR stock
Bart Filius, Dir of ProQR Therapeutics N.V. (PRQR), bought 150,000 shares of PRQR stock worth $231K, per an SEC Form 4 filed Jun 30, 2026.
It was an open-market purchase.
The trade happened on Jun 26, 2026, 4 days before it was made public.
PRQR has moved -15.7% since the trade date, from $1.53 to $1.29 (Oct 23, 2026 close).
- Traded
- Jun 26, 2026
- Disclosed
- Jun 30, 2026
- Filing delay
- 4 days
- Price since
- -15.7%
- Role
- Dir
- Source
- SEC Form 4
More PRQR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.